Abstract
Active pharmaceutical ingredients (APIs) can exist in different polymorphic forms as well as in amorphous state. Polymorphic and amorphous forms of APIs can differ in physicochemical properties which in turn can significantly influence their therapeutic safety and effectiveness of the treatment. This review focuses on benefits and limitations of polymorphic and amorphous forms of APIs used in preformulation and formulation studies. Authors present their work on safety precautions for the use of polymorphic and amorphous forms of APIs, analytical techniques used for their identification as well as methods of their preparation especially in regard to limitations of labile APIs.
Keywords: Polymorphs, amorphous form, active pharmaceutical ingredients, solubility, preparation of polymorphic and amorphous forms.
Current Pharmaceutical Design
Title:Benefits and Limitations of Polymorphic and Amorphous Forms of Active Pharmaceutical Ingredients
Volume: 22 Issue: 32
Author(s): Alicja Talaczynska, Jakub Dzitko and Judyta Cielecka-Piontek
Affiliation:
Keywords: Polymorphs, amorphous form, active pharmaceutical ingredients, solubility, preparation of polymorphic and amorphous forms.
Abstract: Active pharmaceutical ingredients (APIs) can exist in different polymorphic forms as well as in amorphous state. Polymorphic and amorphous forms of APIs can differ in physicochemical properties which in turn can significantly influence their therapeutic safety and effectiveness of the treatment. This review focuses on benefits and limitations of polymorphic and amorphous forms of APIs used in preformulation and formulation studies. Authors present their work on safety precautions for the use of polymorphic and amorphous forms of APIs, analytical techniques used for their identification as well as methods of their preparation especially in regard to limitations of labile APIs.
Export Options
About this article
Cite this article as:
Talaczynska Alicja, Dzitko Jakub and Cielecka-Piontek Judyta, Benefits and Limitations of Polymorphic and Amorphous Forms of Active Pharmaceutical Ingredients, Current Pharmaceutical Design 2016; 22 (32) . https://dx.doi.org/10.2174/1381612822666160804100036
DOI https://dx.doi.org/10.2174/1381612822666160804100036 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Cerebrospinal Fluid Amyloid β42/40 Ratio in the Differentiation of Alzheimers Disease from Non-Alzheimers Dementia
Current Alzheimer Research GHB, GBL and 1,4-BD Addiction
Current Pharmaceutical Design “Evaluation of the Association between Addiction Severity Index and Depression with Adherence to Anti-retroviral Therapy among HIV Infected Patients”
Infectious Disorders - Drug Targets Role of Pituitary Adenylate Cyclase-Activating Polypeptide in Nociception and Migraine
CNS & Neurological Disorders - Drug Targets Hydatid Disease: Current Status of Chemotherapy and Drug Delivery Systems
Current Drug Therapy New Strategies for Managing Anemia of Chronic Kidney Disease
Cardiovascular & Hematological Agents in Medicinal Chemistry Antibiotics and Non-Steroidal Anti-Inflammatory Drugs in Outpatient Practice: Indications and Unwanted Effects in a Gastroenterological Setting
Current Drug Safety Forodesine (BCX-1777, Immucillin H) - A New Purine Nucleoside Analogue: Mechanism of Action and Potential Clinical Application
Mini-Reviews in Medicinal Chemistry Herbal Compounds and Toxins Modulating TRP Channels
Current Neuropharmacology Positron Emission Tomography in Neuroimaging - An Update
Current Medical Imaging Patients Stratification Strategies to Optimize the Effectiveness of Scavenging Biogenic Aldehydes: Towards a Neuroprotective Approach for Parkinson's Disease
Current Neuropharmacology Preconception Counselling: A Five- Year Experience in a Teratology Information Service
Letters in Drug Design & Discovery Overview of Chemistry and Therapeutic Potential of Non-Nitrogen Heterocyclics as Anticonvulsant Agents
Current Neuropharmacology Plant Defensins and Defensin-Like Peptides - Biological Activities and Biotechnological Applications
Current Pharmaceutical Design Oxidative stress and Parkinson’s disease: New hopes in treatment with herbal antioxidants
Current Pharmaceutical Design Effect of Multiple Dietary Supplement Containing Lutein, Astaxanthin, Cyanidin-3-glucoside, and DHA on Accommodative Ability
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Iron Deficiency: The Hidden Miscreant in Inflammatory Bowel Disease
Current Drug Targets Prevention of Colitis-associated Cancer: Natural Compounds that Target the IL-6 Soluble Receptor
Anti-Cancer Agents in Medicinal Chemistry Patent Selections:
Recent Patents on Inflammation & Allergy Drug Discovery Ginseng for Alzheimer's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Current Topics in Medicinal Chemistry